Ray Kimberly M, Price Elissa R, Joe Bonnie N
1 All authors: Department of Radiology and Biomedical Imaging, University of California, San Francisco, Mount Zion Medical Center, 1600 Divisadero St, Rm C250, Mail Box 1667, San Francisco, CA 94115.
AJR Am J Roentgenol. 2015 Feb;204(2):257-60. doi: 10.2214/AJR.14.13558.
OBJECTIVE. The purpose of this article is describe the origins and provisions of breast density legislation and to evaluate these mandates with regard to the balance between the potential benefit of supplementary screening and the substantial risk of false-positive findings and the adjunctive tests they necessitate. CONCLUSION. Many states have passed breast density notification legislation, and federal legislation is pending. These mandates present a number of challenges for patients and physicians. There is no consensus regarding the need for supplementary testing solely because a woman has dense breasts. The failure of density legislation to require insurance coverage in many states further complicates implementation of the mandates.
目的。本文旨在描述乳房密度立法的起源和规定，并就补充筛查的潜在益处与假阳性结果的重大风险及其所需的辅助检查之间的平衡来评估这些要求。结论。许多州已通过乳房密度通知立法，联邦立法也在待决中。这些要求给患者和医生带来了诸多挑战。对于仅因女性乳房致密就需要进行补充检测这一点，尚无共识。许多州的密度立法未要求保险覆盖，这进一步使这些要求的实施复杂化。
